The efficacy of hyperthermic intravesical chemotherapy in high-risk non-muscle-invasive bladder cancer patients with BCG intolerance.

Fatih AkbulutYasar PazırAbdullah EsmerayAkif ErbinFaruk OzgorOmer Sarilar

Published in: Urologia (2023)

This study demonstrated that adjuvant HIVEC with MMC is an effective and safe alternative bladder sparing treatment in BCG intolerant high risk papillary NMIBC patients.

Keyphrases

muscle invasive bladder cancer
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
early stage
spinal cord injury
prognostic factors
peritoneal dialysis
urinary tract
minimally invasive